13th Jan 2010 12:11
13 January 2010
Sinclair Pharma plc ("Sinclair" or the "Company")
Director dealings
Godalming, UK: Sinclair Pharma plc ("Sinclair": SPH:L), the international specialty pharma company, has been informed that following the recent fundraising the shareholdings of certain directors have changed. Details of the directors' shareholdings are set out in the table below:
|
Interest after the Fundraising |
|||||||||
|
Director |
Price |
Shareholding pre fundraising |
Shares obtained in the fundraising |
Number of Ordinary Shares |
% of total issued share capital |
||||
|
Chris Spooner |
32p |
3,849,978 |
2,568,140 |
6,418,118 |
4.0 |
||||
|
Christophe Foucher |
32p |
4,500 |
- |
4,500 |
0.0 |
||||
|
Grahame Cook |
32p |
600,000 |
100,000 |
700,000 |
0.4 |
||||
|
Penny Freer |
32p |
100,000 |
- |
100,000 |
0.1 |
||||
|
Jean Charles Tschudin |
32p |
442,391 |
189,997 |
632,388 |
0.4 |
||||
For further information please contact:
Sinclair Pharma plc Tel: +44 (0) 1483 410 600
Alan Olby, Company Secretary
Singer Capital Markets Ltd Tel: +44 (0)20 3205 7500
Shaun Dobson
Claes Spång
Related Shares:
Sinclair Pharma